Heparin-binding protein (HBP/CAP37) - A link to endothelin-1 in endotoxemia-induced pulmonary oedema?

Acta Anaesthesiologica Scandinavica

Volumn 58, Issue 5, 2014, Pages 549-559

  Persson, B P ^a,b   Halldorsdottir, H ^a,b   Lindbom, L ^b   Rossi, P ^a,b   Herwald, H ^c   Weitzberg, E ^a,b   Oldner, A ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR; HEPARIN BINDING PROTEIN; MYELOPEROXIDASE; SARAFOTOXIN S6C; TEZOSENTAN; ANTIMICROBIAL CATIONIC PEPTIDE; CARRIER PROTEIN; CATIONIC ANTIMICROBIAL PROTEIN CAP 37, HUMAN; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; ENDOTOXIN; ENDOTOXIN, ESCHERICHIA COLI; PLASMA PROTEIN; PYRIDINE DERIVATIVE; SARAFOTOXINS S6; TETRAZOLE DERIVATIVE; VIPER VENOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD GAS; CONTINUOUS INFUSION; CONTROLLED STUDY; ENDOTOXEMIA; HEART INDEX; HEART OUTPUT; HEMODYNAMICS; LEUKOCYTE COUNT; LUNG ARTERY PRESSURE; LUNG COMPLIANCE; LUNG EDEMA; LUNG EXTRAVASCULAR FLUID; LUNG FLUID; LUNG GAS EXCHANGE; LUNG VASCULAR RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; PULMONARY HYPERTENSION; SEPSIS; SWINE; VASCULAR RESISTANCE; AGONISTS; ANIMAL; BLOOD; CAPILLARY LEAK SYNDROME; COMPLICATION; DOSE RESPONSE; DRUG EFFECTS; FEMALE; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ACTIVATION; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY EDEMA; RANDOMIZATION; TOXICITY;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; CAPILLARY LEAK SYNDROME; CARRIER PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN RECEPTOR ANTAGONISTS; ENDOTHELIN-1; ENDOTOXEMIA; ENDOTOXINS; EXTRAVASCULAR LUNG WATER; FEMALE; HEMODYNAMICS; INFLAMMATION; INFUSIONS, INTRAVENOUS; LEUKOCYTE COUNT; MALE; NEUTROPHIL ACTIVATION; PULMONARY EDEMA; PYRIDINES; RANDOM ALLOCATION; RECEPTOR, ENDOTHELIN B; SUS SCROFA; SWINE; TETRAZOLES; VIPER VENOMS;

EID: 84898803738     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/aas.12301     Document Type: Article

References (30)

1. Lee WL, Slutsky AS,. Sepsis and endothelial permeability. N Engl J Med 2010; 363: 689-691.
2. Annane D, Bellissant E, Cavaillon J,. Septic shock. Lancet 2005; 365: 63-78.
3. Wanecek M, Weitzberg E, Rudehill A, Oldner A,. The endothelin system in septic and endotoxin shock. Eur J Pharmacol 2000; 407: 1-15.
4. Barton M, Yanagisawa M,. Endothelin: 20 years from discovery to therapy. Can J Physiol Pharmacol 2008; 86: 485-498.
5. de Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR,. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A 1988; 85: 9797-9800.
6. Fukuroda T, Fujikawa T, Ozaki S, Ishikawa K, Yano M, Nishikibe M,. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun 1994; 199: 1461-1465.
7. Persson BP, Rossi P, Weitzberg E, Oldner A,. Inhaled tezosentan reduces pulmonary hypertension in endotoxin-induced lung injury. Shock 2009; 32: 427-434.
8. Rossi P, Wanecek M, Konrad D, Oldner A,. Tezosentan counteracts endotoxin-induced pulmonary edema and improves gas exchange. Shock 2004; 21: 543-548.
9. Kuklin VN, Kirov MY, Evgenov OV, Sovershaev MA, Sjoberg J, Kirova SS, Bjertnaes LJ,. Novel endothelin receptor antagonist attenuates endotoxin-induced lung injury in sheep. Crit Care Med 2004; 32: 766-773.
10. Comellas AP, Briva A,. Role of endothelin-1 in acute lung injury. Transl Res 2009; 153: 263-271.
11. Gautam N, Olofsson AM, Herwald H, Iversen LF, Lundgren-Akerlund E, Hedqvist P, Arfors KE, Flodgaard H, Lindbom L,. Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of vascular permeability. Nat Med 2001; 7: 1123-1127.
12. Rasmussen PB, Bjorn S, Hastrup S, Nielsen PF, Norris K, Thim L, Wiberg FC, Flodgaard H,. Characterization of recombinant human HBP/CAP37/azurocidin, a pleiotropic mediator of inflammation-enhancing LPS-induced cytokine release from monocytes. FEBS Lett 1996; 390: 109-112.
13. Soehnlein O, Lindbom L,. Neutrophil-derived azurocidin alarms the immune system. J Leukoc Biol 2009; 85: 344-351.
14. Linder A, Christensson B, Herwald H, Bjorck L, Akesson P,. Heparin-binding protein: an early marker of circulatory failure in sepsis. Clin Infect Dis 2009; 49: 1044-1050.
15. Linder A, Akesson P, Inghammar M, Treutiger CJ, Linner A, Sunden-Cullberg J,. Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock. Crit Care 2012; 16: R90.
16. Zarpelon AC, Pinto LG, Cunha TM, Vieira SM, Carregaro V, Souza GR, Silva JS, Ferreira SH, Cunha FQ, Verri WA Jr., Endothelin-1 induces neutrophil recruitment in adaptive inflammation via TNF-alpha and CXCL1/CXCR2 in mice. Can J Physiol Pharmacol 2012; 90: 187-199.
17. Eibl G, Hotz HG, Faulhaber J, Kirchengast M, Buhr HJ, Foitzik T,. Effect of endothelin and endothelin receptor blockade on capillary permeability in experimental pancreatitis. Gut 2000; 46: 390-394.
18. Persson BP, Rossi P, Weitzberg E, Lindbom L, Oldner A,. The ET-receptor antagonist tezosentan attenuate pulmonary edema and reduces levels of the neutrophil-derived permeability-promoting protein HBP in experimental sepsis: a novel potential link between ET-1 and edema formation? Intensive Care Med 2011; 37 (Suppl. 1): S219.
19. Pearce ML, Yamashita J, Beazell J,. Measurement of pulmonary edema. Circ Res 1965; 16: 482-488.
20. Selinger SL, Bland RD, Demling RH, Staub NC,. Distribution volumes of [131I] albumin, [14C] sucrose, and 36Cl in sheep lung. J Appl Physiol 1975; 39: 773-779.
21. Sakka SG, Ruhl CC, Pfeiffer UJ, Beale R, McLuckie A, Reinhart K, Meier-Hellmann A,. Assessment of cardiac preload and extravascular lung water by single transpulmonary thermodilution. Intensive Care Med 2000; 26: 180-187.
22. Rossi P, Wanecek M, Rudehill A, Konrad D, Weitzberg E, Oldner A,. Comparison of a single indicator and gravimetric technique for estimation of extravascular lung water in endotoxemic pigs. Crit Care Med 2006; 34: 1437-1443.
23. Kirov MY, Kuzkov VV, Kuklin VN, Waerhaug K, Bjertnaes LJ,. Extravascular lung water assessed by transpulmonary single thermodilution and postmortem gravimetry in sheep. Crit Care 2004; 8: R451-458.
24. Hemsen A,. Biochemical and functional characterization of endothelin peptides with special reference to vascular effects. Acta Physiol Scand Suppl 1991; 602: 1-61.
25. Dingemanse J, Clozel M, van Giersbergen PL,. Pharmacokinetics and pharmacodynamics of tezosentan, an intravenous dual endothelin receptor antagonist, following chronic infusion in healthy subjects. Br J Clin Pharmacol 2002; 53: 355-362.
26. Rossi P, Oldner A, Wanecek M, Leksell LG, Rudehill A, Konrad D, Weitzberg E,. Comparison of gravimetric and a double-indicator dilution technique for assessment of extra-vascular lung water in endotoxaemia. Intensive Care Med 2003; 29: 460-466.
27. Helset E, Kjaeve J, Hauge A,. Endothelin-1-induced increases in microvascular permeability in isolated, perfused rat lungs requires leukocytes and plasma. Circ Shock 1993; 39: 15-20.
28. Mencarelli M, Pecorelli A, Carbotti P, Valacchi G, Grasso G, Muscettola M,. Endothelin receptor a expression in human inflammatory cells. Regul Pept 2009; 158: 1-5.
29. Wanecek M, Oldner A, Sundin P, Alving K, Weitzberg E, Rudehill A,. Effects on haemodynamics by selective endothelin ET(B) receptor and combined endothelin ET(A)/ET(B) receptor antagonism during endotoxin shock. Eur J Pharmacol 1999; 386: 235-245.
30. Urbanowicz W, Sogni P, Moreau R, Tazi KA, Barriere E, Poirel O, Lebrec D, Martin A, Guimont MC, Cazals-Hatem D,. Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic rats. Gut 2004; 53: 1844-1849.